COG Homepage

For Patients and Families

The Children’s Oncology Group provides important information for children and their families from the time of diagnosis, through treatment and following cure. Our experts in childhood cancer are available throughout the United States, Canada and a number of international sites. Find a Children’s Oncology Group location near you, learn more about specific Children's Oncology Group clinical trials and the results post study completion and download our Family Handbook for more information.

Children’s Oncology Group’s Project:EveryChild is our ambitious initiative to find better cures for every type of childhood cancer, no matter how rare. All children with cancer cared for at COG’s more than 200 pediatric cancer programs will be able to participate in Project:EveryChild. Learn more about Project:EveryChild and how you can help lead the way.

Supporting Us

The Children’s Oncology Group is dedicated to improving the outcome for all children with cancer. Our global research team needs your help to turn today’s discoveries into tomorrow’s cures. With more than 90% of children with cancer cared for at COG sites, learn how you can help be part of the cure.

Research Collaborations

The Children’s Oncology Group partners with research scientists from around the world in our efforts to understand the causes of cancer and find more effective treatments for the children we care for. Learn how to become a member of the Children’s Oncology Group. You may also learn more about the COG Supportive Care Guidelines.

Industry Partnership

Partner with the Children’s Oncology Group from laboratory discovery to all phases of clinic trials. Our well-established clinical research infrastructure is dedicated to efficiently delivering results to help develop new treatments and provide the data necessary for filings with global regulatory agencies.

Pediatric Early Phase-Clinical Trial Network (PEP-CTN)

The Children's Oncology Group (COG) is the most experienced organization in the world in clinical development of new therapeutics for children and adolescents with cancer. The Pediatric Early Phase-Clinical Trial Network (PEP-CTN) is comprised of 21 premier Children's Oncology Group (COG) pediatric core member sites in the U.S. and 21 non-core member sites in the U.S., Canada and Australia.

The information and content provided on this website is made available for informational purposes only for children and their families affected by cancer. While the Children's Oncology Group strives to provide accurate and up-to-date information, the information may be out of date or incomplete in certain respects. Please do not rely on this information and seek the care of a qualified medical professional if you have questions regarding a specific medical condition, disease, diagnosis or symptom. The information and content presented herein is not intended to replace the independent clinical judgement, medical advice, screening, health counseling, or other intervention performed by your (or your child's) health care provider. Please contact "911" or your emergency services if this is a health emergency. No endorsement of any specific tests, products, or procedures is made herein.